NM_144668.6:c.919G>A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_144668.6(CFAP251):​c.919G>A​(p.Val307Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0459 in 1,612,296 control chromosomes in the GnomAD database, including 2,057 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.036 ( 134 hom., cov: 32)
Exomes 𝑓: 0.047 ( 1923 hom. )

Consequence

CFAP251
NM_144668.6 missense

Scores

17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.106

Publications

12 publications found
Variant links:
Genes affected
CFAP251 (HGNC:28506): (cilia and flagella associated protein 251) This protein encoded by this gene belongs to the WD repeat-containing family of proteins, which function in the formation of protein-protein complexes in a variety of biological pathways. This family member appears to function in the determination of mean platelet volume (MPV), and polymorphisms in this gene have been associated with variance in MPV. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Sep 2011]
CFAP251 Gene-Disease associations (from GenCC):
  • spermatogenic failure 33
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • non-syndromic male infertility due to sperm motility disorder
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0033690035).
BP6
Variant 12-121934277-G-A is Benign according to our data. Variant chr12-121934277-G-A is described in ClinVar as Benign. ClinVar VariationId is 403606.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAdExome4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.0504 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CFAP251NM_144668.6 linkc.919G>A p.Val307Ile missense_variant Exon 5 of 22 ENST00000288912.9 NP_653269.3 Q8TBY9-1
CFAP251NM_001178003.2 linkc.919G>A p.Val307Ile missense_variant Exon 5 of 18 NP_001171474.1 Q8TBY9-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CFAP251ENST00000288912.9 linkc.919G>A p.Val307Ile missense_variant Exon 5 of 22 1 NM_144668.6 ENSP00000288912.4 Q8TBY9-1
CFAP251ENST00000397454.2 linkc.919G>A p.Val307Ile missense_variant Exon 5 of 18 1 ENSP00000380595.2 Q8TBY9-2
CFAP251ENST00000546044.1 linkn.28G>A non_coding_transcript_exon_variant Exon 1 of 4 3

Frequencies

GnomAD3 genomes
AF:
0.0363
AC:
5521
AN:
152146
Hom.:
132
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00948
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0407
Gnomad ASJ
AF:
0.0923
Gnomad EAS
AF:
0.0370
Gnomad SAS
AF:
0.0536
Gnomad FIN
AF:
0.0254
Gnomad MID
AF:
0.0506
Gnomad NFE
AF:
0.0493
Gnomad OTH
AF:
0.0449
GnomAD2 exomes
AF:
0.0419
AC:
10450
AN:
249180
AF XY:
0.0436
show subpopulations
Gnomad AFR exome
AF:
0.00905
Gnomad AMR exome
AF:
0.0279
Gnomad ASJ exome
AF:
0.0863
Gnomad EAS exome
AF:
0.0303
Gnomad FIN exome
AF:
0.0270
Gnomad NFE exome
AF:
0.0483
Gnomad OTH exome
AF:
0.0457
GnomAD4 exome
AF:
0.0469
AC:
68464
AN:
1460032
Hom.:
1923
Cov.:
30
AF XY:
0.0472
AC XY:
34280
AN XY:
726384
show subpopulations
African (AFR)
AF:
0.00837
AC:
280
AN:
33470
American (AMR)
AF:
0.0289
AC:
1291
AN:
44704
Ashkenazi Jewish (ASJ)
AF:
0.0856
AC:
2236
AN:
26118
East Asian (EAS)
AF:
0.0446
AC:
1772
AN:
39688
South Asian (SAS)
AF:
0.0516
AC:
4451
AN:
86210
European-Finnish (FIN)
AF:
0.0274
AC:
1464
AN:
53340
Middle Eastern (MID)
AF:
0.0496
AC:
286
AN:
5764
European-Non Finnish (NFE)
AF:
0.0485
AC:
53826
AN:
1110420
Other (OTH)
AF:
0.0474
AC:
2858
AN:
60318
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.417
Heterozygous variant carriers
0
3048
6096
9144
12192
15240
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2056
4112
6168
8224
10280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0363
AC:
5532
AN:
152264
Hom.:
134
Cov.:
32
AF XY:
0.0355
AC XY:
2645
AN XY:
74460
show subpopulations
African (AFR)
AF:
0.00948
AC:
394
AN:
41564
American (AMR)
AF:
0.0406
AC:
621
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.0923
AC:
320
AN:
3468
East Asian (EAS)
AF:
0.0369
AC:
191
AN:
5182
South Asian (SAS)
AF:
0.0539
AC:
260
AN:
4826
European-Finnish (FIN)
AF:
0.0254
AC:
270
AN:
10614
Middle Eastern (MID)
AF:
0.0544
AC:
16
AN:
294
European-Non Finnish (NFE)
AF:
0.0493
AC:
3355
AN:
68000
Other (OTH)
AF:
0.0497
AC:
105
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
259
519
778
1038
1297
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
66
132
198
264
330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0473
Hom.:
646
Bravo
AF:
0.0347
TwinsUK
AF:
0.0502
AC:
186
ALSPAC
AF:
0.0493
AC:
190
ESP6500AA
AF:
0.00981
AC:
40
ESP6500EA
AF:
0.0455
AC:
380
ExAC
AF:
0.0421
AC:
5092
Asia WGS
AF:
0.0680
AC:
238
AN:
3478
EpiCase
AF:
0.0442
EpiControl
AF:
0.0463

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.067
BayesDel_addAF
Benign
-0.65
T
BayesDel_noAF
Benign
-0.66
CADD
Benign
0.21
DANN
Benign
0.91
DEOGEN2
Benign
0.0073
T;.
Eigen
Benign
-1.4
Eigen_PC
Benign
-1.4
FATHMM_MKL
Benign
0.25
N
LIST_S2
Benign
0.64
T;T
MetaRNN
Benign
0.0034
T;T
MetaSVM
Benign
-1.1
T
PhyloP100
0.11
PrimateAI
Benign
0.23
T
PROVEAN
Benign
-0.60
N;N
REVEL
Benign
0.23
Sift
Benign
0.25
T;T
Sift4G
Benign
0.28
T;T
Polyphen
0.013
B;.
Vest4
0.048
MPC
0.11
ClinPred
0.0025
T
GERP RS
-5.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.026
gMVP
0.12
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs77540055; hg19: chr12-122372183; COSMIC: COSV56614458; COSMIC: COSV56614458; API